Wall Street analysts expect that LKQ Co. (NASDAQ:LKQ) will announce earnings per share (EPS) of $0.57 for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for LKQ’s earnings. The lowest EPS estimate is $0.49 and the highest is $0.65. LKQ reported earnings per share of $0.54 during the same quarter last year, which suggests a positive year-over-year growth rate of 5.6%. The business is expected to report its next quarterly earnings results on Thursday, February 18th.
According to Zacks, analysts expect that LKQ will report full-year earnings of $2.40 per share for the current year, with EPS estimates ranging from $2.17 to $2.50. For the next fiscal year, analysts forecast that the company will report earnings of $2.72 per share, with EPS estimates ranging from $2.61 to $2.88. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that cover LKQ.
LKQ (NASDAQ:LKQ) last released its earnings results on Thursday, October 29th. The auto parts company reported $0.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.23. LKQ had a return on equity of 14.23% and a net margin of 5.12%. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.95 billion. During the same quarter in the prior year, the company posted $0.61 earnings per share. LKQ’s revenue was down 3.2% on a year-over-year basis.
Several analysts recently issued reports on LKQ shares. TheStreet upgraded LKQ from a “c” rating to a “b-” rating in a report on Thursday, October 22nd. BidaskClub lowered LKQ from a “buy” rating to a “hold” rating in a research note on Thursday, October 29th. ValuEngine lowered LKQ from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 1st. Zacks Investment Research upgraded LKQ from a “hold” rating to a “strong-buy” rating and set a $33.00 price objective on the stock in a research note on Monday, October 5th. Finally, Stifel Nicolaus upped their price objective on LKQ from $44.00 to $48.00 and gave the company a “buy” rating in a research note on Friday, September 11th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $37.86.
The firm that called the Exact Peak of the Dot-Com boom has just issued another major prediction.
Several hedge funds and other institutional investors have recently made changes to their positions in LKQ. Boston Partners increased its stake in shares of LKQ by 22,842.0% during the third quarter. Boston Partners now owns 10,149,326 shares of the auto parts company’s stock worth $281,441,000 after purchasing an additional 10,105,087 shares during the period. Nordea Investment Management AB lifted its position in shares of LKQ by 202.0% during the 2nd quarter. Nordea Investment Management AB now owns 14,234,760 shares of the auto parts company’s stock valued at $364,694,000 after acquiring an additional 9,521,817 shares during the period. Eminence Capital LP grew its holdings in shares of LKQ by 128.9% during the 2nd quarter. Eminence Capital LP now owns 5,386,079 shares of the auto parts company’s stock worth $141,115,000 after purchasing an additional 3,032,606 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its position in shares of LKQ by 1,059.9% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 1,162,924 shares of the auto parts company’s stock worth $32,248,000 after purchasing an additional 1,062,663 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its stake in LKQ by 16.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,502,777 shares of the auto parts company’s stock valued at $180,322,000 after purchasing an additional 941,323 shares in the last quarter. Institutional investors own 92.09% of the company’s stock.
LKQ opened at $36.04 on Monday. LKQ has a 52-week low of $13.31 and a 52-week high of $38.38. The firm has a market capitalization of $10.97 billion, a PE ratio of 18.39 and a beta of 1.73. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.96 and a current ratio of 2.13. The business’s 50-day simple moving average is $31.29 and its 200 day simple moving average is $28.89.
LKQ Company Profile
LKQ Corporation, together with its subsidiaries, distributes replacement parts, components, and systems used in the repair and maintenance of vehicles. It operates in three segments: North America, Europe, and Specialty. The company distributes bumper covers, automotive body panels, and lights, as well as automotive glass products, such as windshields; salvage products, including mechanical and collision parts comprising engines; transmissions; door assemblies; sheet metal products, such as trunk lids, fenders, and hoods; lights and bumper assemblies; scrap metal and other materials to metals recyclers; and brake pads, discs and sensors, clutches, steering and suspension products, filters, and oil and automotive fluids, as well as electrical products, including spark plugs and batteries.
Recommended Story: Neutral Rating
Get a free copy of the Zacks research report on LKQ (LKQ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
15 Healthcare Stocks that Analysts Love
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems, and other healthcare stocks, it can be hard to identify which healthcare companies will outperform the market.
Fortunately, Wall Street’s brightest minds have already done this for us. Every year, analysts issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don’t always get their “buy” ratings right, but it’s worth taking a hard look when several analysts from different brokerages and research firms are giving “strong-buy” and “buy” ratings to the same healthcare stock.
This slide show lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street’s equities research analysts over the last 12 months.
